The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zhivolupov S.A.

Kafedra nervnykh bolezneĭ Voenno-meditsinskoĭ akademii im. S.M. Kirova, Sankt-Peterburg

Butakova Yu.S.

Department of nervous diseases of the Military Medical Academy, primary vascular compartment Novodvinsk City Hospital, Saint Petersburg, Russia

Samartsev I.N.

Kafedra nervnykh bolezneĭ Voenno-meditsinskoĭ akademii im. S.M. Kirova, Sankt-Peterburg

Contemporary paradigm of rational stroke treatment

Authors:

Zhivolupov S.A., Butakova Yu.S., Samartsev I.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(8‑2): 82‑87

DOI: 10.17116/jnevro20161168282-87

Read: 1035 times

Download PDF (RU)
Contact the author
Table of contents

CONTEMPORARY PARADIGM OF RATIONAL STROKE TREATMENT
CONTEMPORARY PARADIGM OF RATIONAL STROKE TREATMENT

To cite this article:

Zhivolupov SA, Butakova YuS, Samartsev IN. Contemporary paradigm of rational stroke treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(8‑2):82‑87. (In Russ.)
https://doi.org/10.17116/jnevro20161168282-87

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The main mechanisms of deve­lopment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18
Primary progressive apha­sia in the neurologist practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):61-66
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Cognitive impairment after major surgical operations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):74-80
The expe­rience of the narcological service medi­cal specialists in the prevention of substance use among adolescents and youth. Russian Journal of Preventive Medi­cine. 2025;(5):62-68
Current approaches to the prevention and treatment of post-thrombotic syndrome. Russian Journal of Preventive Medi­cine. 2025;(5):111-116
Comparative analysis of preventive action of drinking sulfate mine­ral water on neurohormonal and immune regu­lation organs in radiation expo­sure to rats. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(2):45-51
The known and new ideas about the mechanism of action and the spectrum of effe­cts of Mexi­dol. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):22-33
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124
Abstract:

Stroke was and remains one of the world’s leading medical and social problems. Nowadays we are watching permanent sometimes cardinal changes in view about etiology, pathogenetic mechanisms and therapy of patients with stroke. In this work there have been elucidated contemporary theoretical and practical aspects of stroke treatment and prophylaxis based on the results of multicenter clinical trials and experience of leading foreign and native specialists. Much attention is devoted to the pharmacotherapy of patients with stroke. It is showed that application of neuroprotective drugs is of great importance, among which antihypoxants with pleiotropic action play a crucial role (mexidol).

Keywords:

stroke
therapy
prophylaxis
neuroprotection
antihypoxants
mexidol

Authors:

Zhivolupov S.A.

Kafedra nervnykh bolezneĭ Voenno-meditsinskoĭ akademii im. S.M. Kirova, Sankt-Peterburg

Butakova Yu.S.

Department of nervous diseases of the Military Medical Academy, primary vascular compartment Novodvinsk City Hospital, Saint Petersburg, Russia

Samartsev I.N.

Kafedra nervnykh bolezneĭ Voenno-meditsinskoĭ akademii im. S.M. Kirova, Sankt-Peterburg

Close metadata

References:

  1. Skvortsova VI, Chazova IE, Stakhovskaya LV, Pryanikova NA. Pervichnaya profilaktika insul'ta. M.: Meditsina; 2006. (In Russ.).
  2. Schnohr P, Lange P, Scharling H, Jensen JS. Long-term physical activity in leisure time and mortality from coronary heart disease, stroke, respiratory diseases, and cancer. The Copenhagen City Heart Study. Eur J Cardiovasc Prev Rehabil. 2006;13(2):73-179. doi: 10.1097/01.hjr.0000198923.80555.b7
  3. Wolff T, Miller T, Ko S. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;150:405-410. doi: 10.7326/0003-4819-150-6-200903170-00009
  4. Meseguer E, Lavallée PC, Mazighi M, Labreuche J, Cabrejo L, Olivot J-M, Abboud H, Slaoui T, Lapergue B, Guidoux C, Klein IF, Touboul P-J, Amarenco P. Yield of systematic transcranial doppler in patients with transient ischemic attack. Ann Neurol. 2010;68(9):17. doi: 10.1002/ana.21921
  5. Bhattacharya P, Taraman S, Shankar L, Chaturvedi S, Madhavan R. Clinical profiles, complications, and disability in cocaine-related ischemic stroke. J Stroke Cerebrovasc Dis. 2011;20(5):443-449. doi: 10.1016/j.jstrokecerebrovasdis.2010.02.017
  6. Skvortsova VI, Limborskaya SA, Slominskii PA, Kol'tsova EA, Kondrat'eva EA. Gene polymorphism of angiotensin-converting enzyme in patients with ischemic disease of the brain. Zhurn nevrologii i psikhiatrii. 2001;3:21-27. (In Russ.).
  7. Goldstein LB. Novel platelet antiagregants and the changing landscape of stroke prevention. The Lancet Neurology. 2011;10(8):678-680. doi: 10.1016/s1474-4422(11)70151-x
  8. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Brit Med J. 2002;324:71-86. doi: 10.1136/bmj.324.7329.71
  9. Gusev EI, Skvortsova VI. Ishemiya golovnogo mozga. M.: Meditsina; 2001. (In Russ.).
  10. Suslina ZA, Maksimova MYu, Fedorova TN. Oxidative stress and principal directions of neuroprotection in disorders of cerebral circulation Nevrologicheskii zhurnal. 2007;4:1-5. (In Russ.).
  11. Kasatkin DS. Neurovascular unit as the point of application of certain vasoactive and neuroprotective drugs. Zhurn nevrologii i psikhiatrii. 2012;112(10):103-108. (In Russ.).
  12. National Institute of Neurological Disorders and Stroke rt-PAStroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587. doi: 10.1056/NEJM199512143332401
  13. Bhattacharya P, Taraman S, Shankar L, Chaturvedi S, Madhavan R. Clinical profiles, complications, and disability in cocaine-related ischemic stroke. J Stroke Cerebrovasc Dis. 2011;20(5):443-449. doi: 10.1016/j.jstrokecerebrovasdis.2010.02.017
  14. Izhbuldina GI. Changes in the hemostasis system and free-radical lipid oxidation in the acute stage of ischemic stroke in patients on neuroprotection treatment. Zhurn nevrologii i psikhiatrii (prilozhenie Insul't). 2012;3(2):31-37. (In Russ.).
  15. Ford ES, Li C, Pearson WS, Zhao G, Mokdad AH. Trends in hypercholesterolemia, treatment and control among United States adults. Int J Cardiol. 2010;140:226-235. doi: 10.1016/j.ijcard.2008.11.033
  16. Yano K, Reed DM, Kagan A. Coronary heart disease, hypertension and stroke among Japanese-American men in Hawaii: the Honolulu Heart Program. Hawaii Med J. 1985;297:300-312.
  17. Kamchatnov PR, Abusueva BA, Evzelman MA, Esin RG, Kolyak EV, Novikova LB, Prikazchikov SV, Ryabov AG, Umarova KhYa, Boyko AN. Efficacy of cereton in acute ischemic stroke: results of the trial SOLNTSE. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (prilozhenie Insul't). 2012;3:10-14. (In Russ.).
  18. Odinak MM, Yanishevskiǐ SN, Tsygan NV, Golokhvastov SYu, Vozniuk IA, Trufanov AG. The use of succinates for the correction of metabolic disorders in the penumbra in patients with stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (prilozhenie «Insul't»). 2013;12:55-60. (In Russ.).
  19. Chefranova ZhYu, Makotrova TA, Udachin VA, Koledintseva EV. Efficacy of mexidol in the combination with thrombolytic therapy in patients with ischemic stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;4:49-52. (In Russ.).
  20. Skvortsova VI, Stakhovskaya LV, Nartsyssov YaR, Bodykhov MK, Kichuck IV, Gudkova YuV, Soldatenkova TD, Kondrasheva TT, Kalinina EV, Novichkova MD, Kerbikov OB. The randomized double-blind placebo-controlled study of efficacy and safety of mexidol in the complex therapy of ischemic stroke in the acute period. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (prilozhenie «Insul't»). 2006;18:47-54. (In Russ.).
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.